Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.5B | 14.1B | 13.2B | 14.1B |
Cost of revenue | 4.2B | 4.6B | 4.3B | 5.3B |
Gross profit | 7.3B | 9.5B | 8.9B | 8.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 904.2M | 564.2M | 463.4M | 307.8M |
Operating income | 5.9B | 8.3B | 7.9B | 7.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 801.2M | 745.2M | 517M | 588.9M |
Other income expense | — | — | — | — |
Pretax income | 5.8B | 8.1B | 7.8B | 7.8B |
Tax provision | 1.4B | 1.9B | 1.9B | 1.9B |
Net income | 4.3B | 6.2B | 5.9B | 5.8B |
Basic EPS | — | 17.0 | 16.2 | 16.1 |
Diluted EPS | — | 17.0 | 16.2 | 16.1 |
Basic average shares | — | 363.5M | 363.6M | 363.5M |
Diluted average shares | — | 363.5M | 363.6M | 363.5M |
EBITDA | 6.8B | 9.1B | 8.6B | 8.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |